Dabigatran reduces thrombin-induced platelet aggregation and activation in a dose-dependent manner

Dabigatran in clinical practice: Contemporary overview of the evidence

(2016) Walter Ageno et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Dabigatran and rivaroxaban do not affect AA- and ADP-induced platelet aggregation in patients receiving concomitant platelet inhibitors

(2016) Christoph B. Olivier et al.   JOURNAL OF THROMBOSIS AND THROMBOLYSIS

TRAP-induced platelet aggregation is enhanced in cardiovascular patients receiving dabigatran

(2016) Christoph B. Olivier et al.   THROMBOSIS RESEARCH

The effect of dabigatran and rivaroxaban on platelet reactivity and inflammatory markers

(2015) Noa Zemer-Wassercug et al.   JOURNAL OF THROMBOSIS AND THROMBOLYSIS

Impact of Dabigatran versus Phenprocoumon on ADP Induced Platelet Aggregation in Patients with Atrial Fibrillation with or without Concomitant Clopidogrel Therapy (the Dabi-ADP-1 and Dabi-ADP-2 Trials)

(2015) Amadea M. Martischnig et al.   Biomed Research International

Dabigatran, rivaroxaban, apixaban, argatroban and fondaparinux and their effects on coagulation POC and platelet function tests

(2014) Thomas Eller et al.   CLINICAL CHEMISTRY AND LABORATORY MEDICINE

Performance of coagulation tests in patients on therapeutic doses of rivaroxaban

(2014) Emily M. Hawes et al.   THROMBOSIS AND HAEMOSTASIS

The Effect of Dabigatran Plasma Concentrations and Patient Characteristics on the Frequency of Ischemic Stroke and Major Bleeding in Atrial Fibrillation Patients

(2013) Paul A. Reilly et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Performance of coagulation tests in patients on therapeutic doses of dabigatran: a cross-sectional pharmacodynamic study based on peak and trough plasma levels

(2013) E. M. Hawes et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

The Use of Dabigatran in Elderly Patients

(2011) Matthieu Legrand   ARCHIVES OF INTERNAL MEDICINE

Apixaban, a direct factor Xa inhibitor, inhibits tissue-factor induced human platelet aggregation in vitro: Comparison with direct inhibitors of factor VIIa, XIa and thrombin

(2010) Xiaosui Jiang et al.   THROMBOSIS AND HAEMOSTASIS

Dabigatran versus Warfarin in Patients with Atrial Fibrillation

(2009) Stuart J. Connolly et al.   NEW ENGLAND JOURNAL OF MEDICINE